Inocuidad y calidad de los alimentos
 

Edición en línea: "Residuos en drogas veterinarias"

Ayuda en línea   Terminology

Esta base de datos contiene la información más reciente sobre los niveles máximos de residuos en drogas veterinarias según lo recomendado por JECFA. Todas las monografías publicadas en la FAO sobre Alimentación y Nutrición, Papeles 41, son accesibles en formato electrónico. Estas monografías están sólo disponibles en inglés aunque algunas partes de la base de datos, como la página de preguntas y también una información básica se puede encontrar en árabe, chino, español, francés e inglés.

Medicamento veterinario Neomycin
La clase funcional Antimicrobial agent
Ultima evaluación 2003
Reunión de JECFA 60
IDA 0-60 µg/kg bw
Estatus de IDA Full
Monografías de residuos  
Definición del residuo Parent drug
Límites máximos para residuos
(LMR) recomendados
CattleFat500 µg/kgF
CattleKidney10000 µg/kgF
CattleLiver500 µg/kgF
CattleMilk1500 µg/kgF
CattleMuscle500 µg/kgF
ChickenEggs500 µg/kgF
ChickenFat500 µg/kgF
ChickenKidney10000 µg/kgF
ChickenLiver500 µg/kgF
ChickenMuscle500 µg/kgF
DuckFat500 µg/kgF
DuckKidney10000 µg/kgF
DuckLiver500 µg/kgF
DuckMuscle500 µg/kgF
GoatFat500 µg/kgF
GoatKidney10000 µg/kgF
GoatLiver500 µg/kgF
GoatMuscle500 µg/kgF
PigFat500 µg/kgF
PigKidney10000 µg/kgF
PigLiver500 µg/kgF
PigMuscle500 µg/kgF
SheepFat500 µg/kgF
SheepKidney10000 µg/kgF
SheepLiver500 µg/kgF
SheepMuscle500 µg/kgF
TurkeyFat500 µg/kgF
TurkeyKidney10000 µg/kgF
TurkeyLiver500 µg/kgF
TurkeyMuscle500 µg/kgF
Otras observaciones
El resumen de la evaluación Committee considered the following factors in recommending MRLs:
- An ADI of 0 - 60 mg/kg bodyweight based on a toxicological end-point, which results in a maximum daily intake of 3600 mg for a 60 kg person.
- Neomycin undergoes negligible metabolism following parenteral administration in animals and the parent drug represents the total of the residues present in the tissues.
- Neomycin is the marker residue for tissues, milk and eggs.
- A validated HPLC method with a LOQ of 0.1 mg/mL for neomycin in cow's milk is available and is suitable for routine use.
- Concentrations of neomycin up to 2 mg/l had no effect on bacterial starter cultures used in the production of fermented milk products.
- Data on residues in milk supported an MRL for cow's milk of 1500 mg/kg.
- Information on the registered use patterns for injectable formulations of neomycin in food-producing animals was requested from Governments and considered. The information indicated that use of parenteral formulations is not regarded as good practice in the use of veterinary drugs, and few such products were found to be approved.
- The MRLs for kidney of 20000 mg/kg and for liver of 15000 mg/kg recommended by the Committee at its 52nd Meeting to accommodate use of parenteral formulations are therefore unnecessary.
The Committee, having considered the data submitted since its 43rd meeting, decided to revert to the MRLs for cattle kidney and liver that it had recommended at its 47th meeting.
Based on the consumption of 300 g of muscle, 100 g of liver, 50 g of kidney, 50 g of fat, 1.5 kg of milk and 100 g of eggs, the theoretical maximum daily intake of neomycin residues is 3025 mg. This accounts for 84 % of the ADI of 3600 mg for a person of 60 kg bodyweight.
FNP 41/15